TASP1
Threonine aspartase 1
Also known as: C20orf13, dJ585I14.2, FLJ20212, TASP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6P5
- Gene
- TASP1
- Ensembl
- ENSG00000089123
- Chromosome
- 20
- Canonical length
- 420 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes an endopeptidase that cleaves specific substrates following aspartate residues. The encoded protein undergoes posttranslational autoproteolytic processing to generate alpha and beta subunits, which reassemble into the active alpha2-beta2 heterotetramer. It is required to cleave MLL, a protein required for the maintenance of HOX gene expression, and TFIIA, a basal transcription factor. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
420 residues, UniProt reviewed canonical sequence.
>Q9H6P5|TASP1
1 MTMEKGMSSG EGLPSRSSQV SAGKITAKEL ETKQSYKEKR GGFVLVHAGA GYHSESKAKE
61 YKHVCKRACQ KAIEKLQAGA LATDAVTAAL VELEDSPFTN AGMGSNLNLL GEIECDASIM
121 DGKSLNFGAV GALSGIKNPV SVANRLLCEG QKGKLSAGRI PPCFLVGEGA YRWAVDHGIP
181 SCPPNIMTTR FSLAAFKRNK RKLELAERVD TDFMQLKKRR QSSEKENDSG TLDTVGAVVV
241 DHEGNVAAAV SSGGLALKHP GRVGQAALYG CGCWAENTGA HNPYSTAVST SGCGEHLVRT
301 ILARECSHAL QAEDAHQALL ETMQNKFISS PFLASEDGVL GGVIVLRSCR CSAEPDSSQN
361 KQTLLVEFLW SHTTESMCVG YMSAQDGKAK THISRLPPGA VAGQSVAIEG GVCRLESPVNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TASP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 27 nTPM
- thymus: 12 nTPM
- parathyroid gland: 8.2 nTPM
- fallopian tube: 7.6 nTPM
- thyroid gland: 7.3 nTPM
- pituitary gland: 7 nTPM
Single-cell type
- thymocytes: 1,667 nCPM
- lactotrophs: 346 nCPM
- somatotrophs: 314 nCPM
- gonadotrophs: 262 nCPM
- corticotrophs: 253 nCPM
- thyrotrophs: 250 nCPM
Immune cell
- plasmacytoid DC: 19 nTPM
- naive CD4 T-cell: 19 nTPM
- NK-cell: 15 nTPM
- naive CD8 T-cell: 14 nTPM
- T-reg: 13 nTPM
- memory CD4 T-cell: 13 nTPM
Brain region
- choroid plexus: 18 nTPM
- white matter: 15 nTPM
- cerebral cortex: 15 nTPM
- hypothalamus: 15 nTPM
- thalamus: 14 nTPM
- midbrain: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TASP1.
Disease | AllUniProt
Conditions TASP1 is implicated in, by any mechanism.
- Suleiman-El-Hattab syndrome (SULEHS) MIM:618950
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 92 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Suleiman-El-Hattab syndrome
- Global developmental delay
- Multiple congenital anomalies
- Developmental delay
- Distinctive facial features
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.61
- gnomAD missense Z
- 1.58
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase T2, asparaginase 2
- Nucleophile aminohydrolases, N-terminal
- Asparaginase
- Threonine aspartase 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TASP1 as an antibody target. Whether an autoantibody or antibody against TASP1 could matter depends on whether native TASP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TASP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TASP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...